 Enlivex Therapeutics Ltd NASDAQ:ENLV is surging today, up 21.8 at 12.39 at last check, after the drug maker said Israels health ministry allowed it to kick off a mid-stage clinical trial to test its experimental therapy, Allocetra, in severe and critical Covid-19 patients with acute respiratory distress syndrome. 